WEST PALM BEACH, Fla., Sept. 24, 2012 /PRNewswire/ -- SurgLine International Inc. ("SurgLine") (SGLN.PK) is providing this update regarding trading in the company's securities.

SurgLine International, Inc. was named in an Order of Suspension of Trading (the "Order") dated September 17, 2012 from the US Securities and Exchange Commission (the "SEC"). Pursuant to the Order, trading in the Company's securities is suspended from September 17, 2012 through September 28, 2012. According to the Order, the SEC states, that it appears that there is a lack of current and accurate information and questions have arisen concerning the adequacy and accuracy of press releases and public filings concerning the Company's operations.

Upon receipt of the Order, the company immediately began an action plan to remedy the situation.

The Company has been in contact with the SEC and pursuant to those communications the Company is cooperating with the SEC and will be voluntarily producing documents in support of all statements under inquiry, in our public filings, press releases and agreements, if any.

The Company is working with broker dealer(s) that upon the automatic lifting of the suspension will be filing the necessary Form 15c2-11 with the Financial Industry Regulatory Agency ("FINRA"). Once approved by FINRA, the Company would be able to resume trading on the Over the Counter Quotation Board ("OTCQB"). It is important to note, that while there are no mandatory time responses from FINRA, the Company will work diligently with FINRA in processing the appropriate forms and any questions that may arise during the process.